Research reveals that reducing anticholinergic burden can significantly enhance cognitive function in patients with psychosis, offering new treatment insights.
Albert Dickan, MD
Advertisement
Dr Dickan is a third-year psychiatry resident at Creighton University.
Articles by Albert Dickan, MD
Recent research demonstrated that xanomeline-trospium is more efficacious than placebo in treating positive and negative psychotic symptoms in adults with schizophrenia.
How efficacious is brexpiprazole as a treatment for agitation associated with Alzheimer disease?
Advertisement
Latest Updated Articles
Exploring the Role of Brexpiprazole in Alzheimer Dementia AgitationPublished: January 16th 2024 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Muscarinic Cholinergic Circuitry in Schizophrenia: Our Evolving Understanding
2
Mental Health Grants Cut Then Restored in 24 Hours: Leading Organizations React to Environment of Uncertainty
3
sNDA Submission: Igalmi for Acute Treatment of Agitation Associated With Bipolar Disorders or Schizophrenia in Outpatient Setting
4
Integrating Nutritional Guidance Into Psychiatric Practice
5